Gene · 11096
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiR-217 Regulates SIRT1 Expression and Promotes Inflammatory and Apoptotic Responses in Osteoarthritis. | Genes (Basel) | 2023 | 38136977 | PubTator, text mining | PubMed |
| Oleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer. | Antioxidants (Basel) | 2023 | 38136231 | PubTator, text mining | PubMed |
| PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells. | JCI Insight | 2023 | 38131378 | PubTator, text mining | PubMed |
| Application and development of hydrogel biomaterials for the treatment of intervertebral disc degeneration: a literature review. | Front Cell Dev Biol | 2023 | 38130952 | PubTator, text mining | PubMed |
| Unraveling cartilage degeneration through synergistic effects of hydrostatic pressure and biomimetic temperature increase. | iScience | 2023 | 38125014 | PubTator, text mining | PubMed |
| Five Padua days on muscle and mobility medicine (2024Pdm3) 27 February - 2 March, 2024 at Hotel Petrarca, Thermae of Euganean Hills, Padua, and San Luca Hall, Prato della Valle, Padua, Italy. | Eur J Transl Myol | 2023 | 38112609 | PubTator, text mining | PubMed |
| Curculigoside inhibits osteoarthritis <em>via</em> the regulation of NLRP3 pathway. | Eur J Histochem | 2023 | 38112591 | PubTator, text mining | PubMed |
| Exerkines and osteoarthritis. | Front Physiol | 2023 | 38107476 | PubTator, text mining | PubMed |
| The dual pro-inflammatory and bone-protective role of calcitonin gene-related peptide alpha in age-related osteoarthritis. | Arthritis Res Ther | 2023 | 38102666 | PubTator, text mining | PubMed |
| Transcriptome research of human amniocytes identifies hub genes associated with developmental dysplasia in down syndrome. | Aging (Albany NY) | 2023 | 38095646 | PubTator, text mining | PubMed |
| Recent advances in extracellular vesicle engineering and its applications to regenerative medicine. | Biomater Res | 2023 | 38082304 | PubTator, text mining | PubMed |
| pH-sensing G protein-coupled orphan receptor GPR68 is expressed in human cartilage and correlates with degradation of extracellular matrix during OA progression. | PeerJ | 2023 | 38077417 | PubTator, text mining | PubMed |
| Role of ADAM and ADAMTS proteases in pathological tissue remodeling. | Cell Death Discov | 2023 | 38071234 | PubTator, text mining | PubMed |
| Regulation of Peptidase Activity beyond the Active Site in Human Health and Disease. | Int J Mol Sci | 2023 | 38069440 | PubTator, text mining | PubMed |
| The Role of Extracellular Vesicles in the Pathogenesis and Treatment of Rheumatoid Arthritis and Osteoarthritis. | Cells | 2023 | 38067147 | PubTator, text mining | PubMed |
| A novel biomarker of MMP-cleaved cartilage intermediate layer protein-1 is elevated in patients with rheumatoid arthritis, ankylosing spondylitis and osteoarthritis. | Sci Rep | 2023 | 38066013 | PubTator, text mining | PubMed |
| Cabozantinib prevents AGEs-induced degradation of type 2 collagen and aggrecan in human chondrocytes. | Aging (Albany NY) | 2023 | 38059882 | PubTator, text mining | PubMed |
| Double-edged role of mechanical stimuli and underlying mechanisms in cartilage tissue engineering. | Front Bioeng Biotechnol | 2023 | 38053849 | PubTator, text mining | PubMed |
| Risk of metabolic abnormalities in osteoarthritis: a new perspective to understand its pathological mechanisms. | Bone Res | 2023 | 38052778 | PubTator, text mining | PubMed |
| The importance of BMPs and TGF-βs for endochondral bone repair - A longitudinal study in hip arthroplasty patients. | Bone Rep | 2023 | 38047271 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11096/papers?page=14